Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +40.41%
#2 Bitway Bitway +29.57%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.57%
#4 Starpower Starpower +22.57%
#5 aelf aelf +18.30%
#6 Pons Pons +15.67%
#7 Decred Decred +12.50%
#8 Ribbita by Virtuals Ribbita by Virtuals +11.55%
#9 DAPPOS DAPPOS +9.30%
#10 Venom Venom +8.73%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
शेयरों में रैंक #30825
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
शेयर मूल्य
$0.089
अंतिम समन्वयन: 2026-08-17
मार्केट कैप
$15.36M
बदलाव (1 दिन)
50.59%
बदलाव (1 वर्ष)
72.65%
देश
US
व्यापार Inhibitor Therapeutics, Inc. (INTI)

श्रेणी

Healthcare
Inhibitor Therapeutics, Inc. (INTI) के लिए P/B अनुपात
2026 को P/B अनुपात TTM: 0
Inhibitor Therapeutics, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/B अनुपात 0 था।
Inhibitor Therapeutics, Inc. के लिए 2026 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE